AbbVie Inc. stock outperforms competitors on strong trading day
Shares of AbbVie Inc. ABBV rose 1.79% to $200.88 Thursday, on what proved to be an all-around poor trading session for the ...
AbbVie Appears Ready To Move Higher
AbbVie's growth thrives on strong earnings, a robust immunology portfolio, and diversification. See why ABBV stock is a ...
Daily3d
Abbvie CEO Robert A Michael to assume additional role of Board Chairman
AbbVie has announced that its board of directors has unanimously elected chief executive officer (CEO) Robert A. Michael to assume the additional position of chairman, effective ...
Hosted on MSN3d
Beyond the Possible: How AbbVie Uses Technology to Transform Medicines for Patients
AbbVie is using innovative technologies like AI, wearables and automation to speed up drug discovery, clinical trials, and ...
Pharmabiz4d
AbbVie appoints CEO Robert A Michael as chairman of the board of directors
AbbVie appoints CEO Robert A Michael as chairman of the board of directors: North Chicago, Illinois Monday, February 17, 2025, 13:00 Hrs [IST] AbbVie announced that its board of d ...